|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
提交 2022-01-11
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
2509–2815(307 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
分辨率 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
提交 2022-01-11
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
2509–2815(307 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
分辨率 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
提交 2022-01-11
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
2509–2815(307 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
分辨率 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
提交 2022-01-11
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 4
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 D
2509–2815(307 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
分辨率 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
提交 2022-01-11
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 5
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 E
2509–2815(307 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
分辨率 2.60 Å
R-free 0.241
|
|
7WKU
Structure of PDCoV Mpro in complex with an inhibitor
提交 2022-01-11
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 6
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 F
2509–2815(307 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
BATCH MODE;291 K;0.1M sodium citrate (pH 5.1), 4% (w/v) polyethylene glycol 6000
|
分辨率 2.60 Å
R-free 0.241
|
|
9UOS
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 8
提交 2025-04-26
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
2509–2809(301 aa)
链 D
2509–2809(301 aa)
|
未记录
|
A1EPZ (2~{S})-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.73 Å
R-free 0.260
|
|
9UOS
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 8
提交 2025-04-26
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 B
2509–2809(301 aa)
链 E
2509–2809(301 aa)
|
未记录
|
A1EPZ (2~{S})-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.73 Å
R-free 0.260
|
|
9UOS
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 8
提交 2025-04-26
|
配体/离子不同
结构质量不同
|
Assembly 3
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 C
2509–2809(301 aa)
链 F
2509–2809(301 aa)
|
未记录
|
A1EPZ (2~{S})-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-~{N}-[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.73 Å
R-free 0.260
|
|
9X7D
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with nirmatrelvir
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
2509–2809(301 aa)
链 E
2509–2809(301 aa)
|
未记录
|
4WI (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.28 Å
R-free 0.249
|
|
9X7D
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with nirmatrelvir
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 B
2509–2809(301 aa)
链 D
2509–2809(301 aa)
|
未记录
|
4WI (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.28 Å
R-free 0.249
|
|
9X7D
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with nirmatrelvir
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 3
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 C
2509–2809(301 aa)
链 F
2509–2809(301 aa)
|
未记录
|
4WI (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.28 Å
R-free 0.249
|
|
9X7F
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 1
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
2509–2809(301 aa)
链 B
2509–2809(301 aa)
|
未记录
|
A1D7G (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.64 Å
R-free 0.244
|
|
9X7F
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 1
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 C
2509–2809(301 aa)
链 D
2509–2809(301 aa)
|
未记录
|
A1D7G (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.64 Å
R-free 0.244
|
|
9X7F
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 1
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 3
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 E
2509–2809(301 aa)
链 F
2509–2809(301 aa)
|
未记录
|
A1D7G (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.64 Å
R-free 0.244
|
|
9X7H
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 6
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
2509–2809(301 aa)
链 B
2509–2809(301 aa)
|
未记录
|
A1D7M (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-(methylsulfonylamino)butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.56 Å
R-free 0.244
|
|
9X7H
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 6
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 C
2509–2809(301 aa)
链 D
2509–2809(301 aa)
|
未记录
|
A1D7M (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-(methylsulfonylamino)butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.56 Å
R-free 0.244
|
|
9X7H
Crystal structure of PDCoV 3CL protease (3CLpro) in complex with compound 6
提交 2025-10-16
|
配体/离子不同
结构质量不同
|
Assembly 3
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 E
2509–2809(301 aa)
链 F
2509–2809(301 aa)
|
未记录
|
A1D7M (2~{S})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[(2~{S})-3,3-dimethyl-2-(methylsulfonylamino)butanoyl]amino]-4-methyl-pentanamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;0.5-2% PEG6000, 100 mM sodium citrate, pH 4.6-5.25
|
分辨率 2.56 Å
R-free 0.244
|